v3.25.2
Shareholders' Equity (Details)
$ / shares in Units, $ in Thousands
3 Months Ended
Dec. 31, 2025
shares
Mar. 31, 2025
USD ($)
$ / shares
shares
Mar. 31, 2024
shares
Mar. 31, 2025
₪ / shares
Dec. 31, 2024
$ / shares
shares
Shareholders’ Equity [Line Items]          
Share capital amount authorized | $   $ 20,000,000      
Common stock, shares authorized | shares   200,000,000     200,000,000
Common stock, per share | (per share)   $ 0.1   ₪ 0.1 $ 0.1
Intrinsic value of options outstanding | $   $ 0      
Intrinsic value of exercisable options | $   81      
Intrinsic value of options vested | $   $ 0      
Weighted-average remaining contractual life of outstanding options   5 months 8 days      
Weighted-average remaining contractual life of exercisable options   5 months 8 days      
Weighted average vesting period   2 years 1 month 2 days      
Options, expiration period   10 years      
Shares available for future issuance | shares   566,962      
Granted shares | shares   922,688      
Forecast [Member]          
Shareholders’ Equity [Line Items]          
Number of options vested | shares 40,000        
Restricted Stock Units (RSUs) [Member]          
Shareholders’ Equity [Line Items]          
Unrecognized compensation cost | $   $ 10,054      
Granted shares | shares   922,688 1,510,000    
Minimum [Member] | Restricted Stock Units (RSUs) [Member]          
Shareholders’ Equity [Line Items]          
Vesting period for plan   1 year      
Maximum [Member] | Restricted Stock Units (RSUs) [Member]          
Shareholders’ Equity [Line Items]          
Vesting period for plan   4 years